4//SEC Filing
Thornton Michael Milos 4
Accession 0001209191-22-060895
CIK 0001681682other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:00 PM ET
Size
5.0 KB
Accession
0001209191-22-060895
Insider Transaction Report
Form 4
Thornton Michael Milos
Chief Technology Officer
Transactions
- Purchase
Common Stock
2022-12-09$3.40/sh+1,500$5,100→ 19,139 total
Footnotes (1)
- [F1]On December 9, 2022, the Issuer effected a 1-for-20 reverse stock split (the "Reverse Stock Split") of its outstanding Common Stock. The number of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001706297
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 4:00 PM ET
- Size
- 5.0 KB